Most women taking relugolix for uterine fibroid-related heavy menses achieve amenorrhea

SAN DIEGO — About 70% of women with uterine fibroid-related heavy menstrual bleeding who took relugolix combination therapy experienced amenorrhea, according to data presented at the ACOG Annual Clinical & Scientific Meeting.
“Of the remaining women who had either cyclic or irregular bleeding, approximately half had spotting or light or moderate bleeding that was considered within the normal range for menstrual blood loss,” Andrea S. Lukes, MD, MHSc, FACOG, principal investigator of the study and founder of Carolina Women’s Research and Wellness Center in Durham,

SAN DIEGO — About 70% of women with uterine fibroid-related heavy menstrual bleeding who took relugolix combination therapy experienced amenorrhea, according to data presented at the ACOG Annual Clinical & Scientific Meeting.
“Of the remaining women who had either cyclic or irregular bleeding, approximately half had spotting or light or moderate bleeding that was considered within the normal range for menstrual blood loss,” Andrea S. Lukes, MD, MHSc, FACOG, principal investigator of the study and founder of Carolina Women’s Research and Wellness Center in Durham,